+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bacterial & Viral Specimen Collection Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5206472
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bacterial & Viral Specimen Collection Market grew from USD 23.10 billion in 2024 to USD 25.45 billion in 2025. It is expected to continue growing at a CAGR of 9.97%, reaching USD 40.87 billion by 2030.

In an era where rapid, accurate pathogen detection is pivotal to public health, the bacterial and viral specimen collection market sits at the forefront of innovation and response readiness. This executive summary offers a comprehensive exploration of the forces reshaping this critical industry. Beginning with an overview of current market dynamics, we delve into the transformative shifts driving technological adoption and process optimization. We then examine the cumulative impact of the United States’ 2025 tariff adjustments on supply chains, procurement costs, and global partnerships. A deep dive into segmentation provides clarity on how collection types, end-use applications, device categories, user profiles, organism types, sample phases, procedural approaches, material compositions, and professional roles define submarket behaviors. Regional insights spotlight growth trajectories across the Americas, Europe, Middle East & Africa, and Asia-Pacific. Key corporate activities illustrate competitive positioning among leading players. Finally, actionable recommendations guide industry leaders toward strategic investments, and a clear call to action connects decision-makers with our Associate Director of Sales & Marketing to obtain the full, in-depth market report.

Transformative Shifts in Technology, Process, and End-User Dynamics

The specimen collection market has evolved beyond simple swabbing and vial labeling, propelled by accelerating demands for point-of-care diagnostics and decentralized testing. Advances in sampling technologies now include flocked swabs that enhance sample release compared to traditional cotton wool and foam options, alongside transport medium kits designed for pathogen preservation during transit. Non-invasive procedures for saliva and urine collection are reducing patient discomfort and increasing compliance, while invasive methods for blood and stool sampling remain indispensable for comprehensive microbial profiling. In academic and research institutes, innovations in dishes and plates support high-throughput screening, whereas in hospitals and specialized clinics, rapid diagnostics capitalize on laboratory-based testing and point-of-care platforms. Antibacterial and antiviral treatment monitoring is shifting therapeutic decision-making toward personalized approaches, and liquid, mixed, and solid sample phases are accommodated through emerging material compositions-from biodegradable compostable polymers to robust synthetic matrices. General practitioners, laboratory technologists, and research scientists drive adoption, collectively shaping a landscape where agility, specificity, and biosafety define competitive advantage.

Assessing the Cumulative Impact of U.S. 2025 Tariff Adjustments

The introduction of new tariffs by the United States in 2025 has introduced significant headwinds for global specimen collection supply chains. Import duties on transport medium kits, specialized flocked swabs, and laboratory glassware have driven procurement costs upward, challenging margins for diagnostic laboratories and home care service providers alike. Tariffs on cotton wool and foam for traditional swabs exacerbate material shortages, forcing manufacturers to diversify sourcing from regions beyond North America. In turn, many suppliers have accelerated partnerships in Asia-Pacific and Europe to mitigate cost pressures, but longer lead times and logistical complexities persist. Hospitals and specialized clinics are reporting incremental budget reallocations toward inventory buffering, while research institutions are seeking alternative suppliers to maintain uninterrupted study protocols. At the same time, import duties on dishes and plates used for high-throughput bacterial and viral assays have prompted consolidation among distributors to achieve economies of scale. The net effect is a recalibrated market where strategic supplier relationships and agile sourcing strategies determine resilience against tariff-driven disruptions.

Deep Dive into Key Segmentation Dimensions for Market Understanding

Navigating the specimen collection market requires an appreciation of multiple intersecting segmentation dimensions. Collection modalities range from blood draws and stool sampling to non-invasive saliva and urine procedures, with swabs further classified into nasopharyngeal, rectal, and throat variants. End-use applications encompass laboratory-based and point-of-care diagnostics, research initiatives, and therapeutic monitoring-covering both antibacterial and antiviral treatments. Device categories include dishes and plates for culture assays, flocked swabs prized for sample integrity, traditional swabs composed of cotton wool or foam, and sophisticated transport medium kits. Users span academic and research institutions, diagnostic laboratories, home care environments, hospitals, and specialized clinics. Bacterial targets are differentiated between commensal and pathogenic strains, the latter subdivided into Gram-negative and Gram-positive classifications, while viral pathogens are segmented into DNA and RNA species. Sample phases-liquid, mixed, solid-dictate handling protocols, and procedural approaches range from invasive blood draws to non-invasive saliva collection. Material composition choices between biodegradable compostable or recyclable polymers, natural substrates, and synthetic matrices influence sustainability commitments. Finally, professional stakeholders including clinical professionals, general practitioners, laboratory technologists, and research scientists each navigate distinct purchasing priorities and regulatory frameworks.

Key Regional Insights Across Americas, EMEA, and Asia-Pacific

Regional performance in the specimen collection sector reflects diverse healthcare infrastructures, regulatory landscapes, and pandemic preparedness initiatives. In the Americas, established laboratory networks and home care services drive demand for point-of-care testing kits and rapid swab technologies, while research funding supports novel transport medium development. Europe, Middle East & Africa exhibits a fragmented market where stringent EU regulations influence material composition choices, and emerging economies in the Middle East and Africa prioritize cost-effective traditional swabs and non-invasive collection methods. Asia-Pacific remains a hotbed for manufacturing innovation-from synthetic polymer swab tips to biodegradable plate coatings-coupled with rising investments in high-capacity diagnostic laboratories, particularly in large markets like China and India. Cross-regional collaborations, such as public-private partnerships in EMEA and trade agreements in Asia-Pacific, are accelerating technology transfer and harmonizing quality standards. This tri-regional view underscores the necessity for market participants to tailor distribution strategies, regulatory engagement, and product design to each region’s unique cost structures, accessibility challenges, and growth drivers.

Competitive Landscape and Leading Company Strategies

Competition within the specimen collection market is both dynamic and global. Avantor, Inc. continues to leverage its distribution network for transport medium kits, while Becton, Dickinson, and Company innovates in flocked swab design for enhanced sample recovery. bioMérieux S.A. has integrated diagnostic platforms with proprietary dishes and plates, and Cardinal Health expands its home care testing portfolio. Copan Group’s specialized nasopharyngeal and throat swabs are gaining traction, whereas DiaSorin S.p.A. focuses on combined bacterial and viral assay kits. Dynarex Corporation and Greiner Bio-One International GmbH compete on material sustainability, developing compostable and recyclable collection devices. Hardy Diagnostics emphasizes strength in culture media compatibility, and HiMedia Laboratories Pvt. Ltd delivers cost-effective alternatives in emerging markets. Longhorn Vaccines and Diagnostics, LLC and Lucence Diagnostics Pte Ltd advance research-grade sampling solutions, while Medical Wire & Equipment and Medline Industries, LP. solidify their positions in professional clinical segments. Meridian Bioscience, Inc. and Miraclean Technology Co., Ltd push specialty transport formulations. Pretium Packaging and Puritan Medical Products focus on sterile packaging innovations, and QuidelOrtho Corporation integrates lateral flow technologies. Stellar Scientific targets genomic research kits, Thermo Fisher Scientific, Inc. offers integrated automation solutions, Titan Biotech Ltd. supplies traditional swabs, Trinity Biotech PLC excels in point-of-care assays, Vircell, S.L. provides viral transport media, and Wuxi Nest Biotechnology Co., Ltd. leads in RNA virus sampling components. These players collectively define competitive benchmarks in product quality, regulatory compliance, and supply chain agility.

Actionable Recommendations for Industry Leaders

To thrive amid shifting regulations and cost pressures, industry leaders must pursue strategic initiatives. First, diversifying supplier portfolios across low-tariff regions will mitigate import duty impacts and ensure steady access to cotton wool, foam, and polymer materials. Second, investing in sustainable material research-such as compostable filaments and recyclable synthetic matrices-aligns with tightening environmental regulations and enhances brand reputation. Third, collaborating with diagnostic device manufacturers to co-develop integrated collection-to-analysis workflows can reduce sample handling errors and accelerate time to result. Fourth, leveraging digital traceability systems bolsters regulatory compliance, particularly for cross-border shipments and cold-chain logistics of transport media. Fifth, expanding point-of-care and home collection offerings meets rising consumer demand for decentralized testing, while partnerships with clinical professionals and general practitioners endorse product adoption. Sixth, targeted regional market studies will inform tailored product portfolios and pricing strategies that respond to unique healthcare funding models in the Americas, EMEA, and Asia-Pacific. By implementing these actions, companies can fortify supply chains, differentiate offerings, and sustain profitable growth.

Conclusion: Positioning for Future Market Leadership

The bacterial and viral specimen collection market stands at a critical juncture defined by evolving regulatory frameworks, tariff ramifications, and relentless technological advancement. Robust segmentation and regional analyses reveal nuanced growth pathways, while the competitive landscape underscores the importance of innovation, sustainability, and collaborative development. By integrating strategic sourcing, eco-friendly materials research, digital compliance solutions, and end-to-end workflow partnerships, market participants can not only weather current disruptions but also position themselves as leaders in next-generation diagnostics. As the industry advances toward personalized medicine, rapid outbreak response, and decentralized testing ecosystems, stakeholders with the foresight to adapt will capture the greatest share of emerging opportunities.

Market Segmentation & Coverage

This research report categorizes the Bacterial & Viral Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Blood Collection
  • Saliva Collection
  • Stool Samples
  • Swabs
    • Nasopharyngeal
    • Rectal
    • Throat
  • Urine Collection
  • Diagnostics
    • Laboratory-Based Testing
    • Point-of-Care Testing
  • Research
  • Therapeutics
    • Antibacterial Treatment
    • Antiviral Treatment
  • Dishes and Plates
  • Flocked Swabs
  • Traditional Swabs
    • Cotton Wool
    • Foam
  • Transport Medium Kits
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Home Care Settings
  • Hospitals
  • Specialized Clinics
  • Commensal Bacteria
  • Pathogenic Bacteria
    • Gram-Negative
    • Gram-Positive
  • DNA Viruses
  • RNA Viruses
  • Liquid Samples
  • Mixed Samples
  • Solid Samples
  • Invasive Procedures
  • Non-Invasive Procedures
  • Biodegradable Materials
    • Compostable
    • Recyclable
  • Natural Materials
  • Synthetic Materials
  • Clinical Professionals
  • General Practitioners
  • Laboratory Technologists
  • Research Scientists

This research report categorizes the Bacterial & Viral Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Bacterial & Viral Specimen Collection Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • bioMérieux S.A.
  • Cardinal Health
  • Copan Group
  • DiaSorin S.p.A.
  • Dynarex Corporation
  • Greiner Bio-One International GmbH
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd
  • Longhorn Vaccines and Diagnostics, LLC
  • Lucence Diagnostics Pte Ltd
  • Medical Wire & Equipment
  • Medline Industries, LP.
  • Meridian Bioscience, Inc
  • Miraclean Technology Co., Ltd
  • Pretium Packaging
  • Puritan Medical Products
  • QuidelOrtho Corporation
  • Stellar Scientific
  • Thermo Fisher Scientific, Inc.
  • Titan Biotech Ltd.
  • Trinity Biotech PLC
  • Vircell, S.L.
  • Wuxi Nest Biotechnology Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bacterial & Viral Specimen Collection Market, by Collection Type
8.1. Introduction
8.2. Blood Collection
8.3. Saliva Collection
8.4. Stool Samples
8.5. Swabs
8.5.1. Nasopharyngeal
8.5.2. Rectal
8.5.3. Throat
8.6. Urine Collection
9. Bacterial & Viral Specimen Collection Market, by End-Use Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Laboratory-Based Testing
9.2.2. Point-of-Care Testing
9.3. Research
9.4. Therapeutics
9.4.1. Antibacterial Treatment
9.4.2. Antiviral Treatment
10. Bacterial & Viral Specimen Collection Market, by Collection Devices
10.1. Introduction
10.2. Dishes and Plates
10.3. Flocked Swabs
10.4. Traditional Swabs
10.4.1. Cotton Wool
10.4.2. Foam
10.5. Transport Medium Kits
11. Bacterial & Viral Specimen Collection Market, by End-User
11.1. Introduction
11.2. Academic and Research Institutes
11.3. Diagnostic Laboratories
11.4. Home Care Settings
11.5. Hospitals
11.6. Specialized Clinics
12. Bacterial & Viral Specimen Collection Market, by Bacteria Type
12.1. Introduction
12.2. Commensal Bacteria
12.3. Pathogenic Bacteria
12.3.1. Gram-Negative
12.3.2. Gram-Positive
13. Bacterial & Viral Specimen Collection Market, by Virus Type
13.1. Introduction
13.2. DNA Viruses
13.3. RNA Viruses
14. Bacterial & Viral Specimen Collection Market, by Sample Phase
14.1. Introduction
14.2. Liquid Samples
14.3. Mixed Samples
14.4. Solid Samples
15. Bacterial & Viral Specimen Collection Market, by Procedure Type
15.1. Introduction
15.2. Invasive Procedures
15.3. Non-Invasive Procedures
16. Bacterial & Viral Specimen Collection Market, by Material Composition
16.1. Introduction
16.2. Biodegradable Materials
16.2.1. Compostable
16.2.2. Recyclable
16.3. Natural Materials
16.4. Synthetic Materials
17. Bacterial & Viral Specimen Collection Market, by Professional Segments
17.1. Introduction
17.2. Clinical Professionals
17.3. General Practitioners
17.4. Laboratory Technologists
17.5. Research Scientists
18. Americas Bacterial & Viral Specimen Collection Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Bacterial & Viral Specimen Collection Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Bacterial & Viral Specimen Collection Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Avantor, Inc.
21.3.2. Becton, Dickinson, and Company
21.3.3. bioMérieux S.A.
21.3.4. Cardinal Health
21.3.5. Copan Group
21.3.6. DiaSorin S.p.A.
21.3.7. Dynarex Corporation
21.3.8. Greiner Bio-One International GmbH
21.3.9. Hardy Diagnostics
21.3.10. HiMedia Laboratories Pvt. Ltd
21.3.11. Longhorn Vaccines and Diagnostics, LLC
21.3.12. Lucence Diagnostics Pte Ltd
21.3.13. Medical Wire & Equipment
21.3.14. Medline Industries, LP.
21.3.15. Meridian Bioscience, Inc
21.3.16. Miraclean Technology Co., Ltd
21.3.17. Pretium Packaging
21.3.18. Puritan Medical Products
21.3.19. QuidelOrtho Corporation
21.3.20. Stellar Scientific
21.3.21. Thermo Fisher Scientific, Inc.
21.3.22. Titan Biotech Ltd.
21.3.23. Trinity Biotech PLC
21.3.24. Vircell, S.L.
21.3.25. Wuxi Nest Biotechnology Co., Ltd.
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET MULTI-CURRENCY
FIGURE 2. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET MULTI-LANGUAGE
FIGURE 3. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 22. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 24. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2024 VS 2030 (%)
FIGURE 26. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SALIVA COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY RECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THROAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY URINE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORY-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ANTIBACTERIAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ANTIVIRAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DISHES AND PLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FLOCKED SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COTTON WOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY FOAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRANSPORT MEDIUM KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COMMENSAL BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY GRAM-NEGATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY GRAM-POSITIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DNA VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY RNA VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LIQUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MIXED SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SOLID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COMPOSTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY RECYCLABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY NATURAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SYNTHETIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY CLINICAL PROFESSIONALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY GENERAL PRACTITIONERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY LABORATORY TECHNOLOGISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY RESEARCH SCIENTISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 117. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 119. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 123. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 124. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 127. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 128. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 129. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 130. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 131. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 132. CANADA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 166. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 184. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 185. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 199. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 200. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 201. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 204. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 205. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 206. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 209. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 210. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 211. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 213. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 214. CHINA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 215. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 217. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 219. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 220. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 221. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 222. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 224. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 225. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 226. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 227. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 228. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 229. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 230. INDIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 247. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 248. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 249. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 251. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 252. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 253. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 254. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 255. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 260. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 261. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 262. JAPAN BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 267. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 268. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 269. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY TRADITIONAL SWABS, 2018-2030 (USD MILLION)
TABLE 270. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BACTERIA TYPE, 2018-2030 (USD MILLION)
TABLE 272. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PATHOGENIC BACTERIA, 2018-2030 (USD MILLION)
TABLE 273. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY VIRUS TYPE, 2018-2030 (USD MILLION)
TABLE 274. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE PHASE, 2018-2030 (USD MILLION)
TABLE 275. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 276. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY MATERIAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 277. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY BIODEGRADABLE MATERIALS, 2018-2030 (USD MILLION)
TABLE 278. MALAYSIA BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY PROFESSIONAL SEGMENTS, 2018-2030 (USD MILLION)
TABLE 279. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 280. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
TABLE 281. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY END-USE APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 283. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 284. PHILIPPINES BACTERIAL & VIRAL SPECIMEN COLLECTION MARKET SIZE, BY COLLECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 285. PHILIPPINES BACTE

Companies Mentioned

  • Avantor, Inc.
  • Becton, Dickinson, and Company
  • bioMérieux S.A.
  • Cardinal Health
  • Copan Group
  • DiaSorin S.p.A.
  • Dynarex Corporation
  • Greiner Bio-One International GmbH
  • Hardy Diagnostics
  • HiMedia Laboratories Pvt. Ltd
  • Longhorn Vaccines and Diagnostics, LLC
  • Lucence Diagnostics Pte Ltd
  • Medical Wire & Equipment
  • Medline Industries, LP.
  • Meridian Bioscience, Inc
  • Miraclean Technology Co., Ltd
  • Pretium Packaging
  • Puritan Medical Products
  • QuidelOrtho Corporation
  • Stellar Scientific
  • Thermo Fisher Scientific, Inc.
  • Titan Biotech Ltd.
  • Trinity Biotech PLC
  • Vircell, S.L.
  • Wuxi Nest Biotechnology Co., Ltd.

Methodology

Loading
LOADING...